BUY MBP TRASTUZUMAB VIVITRA 440MG VIAL BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Trastuzumab is a targeted cancer medicine used to treat cancers that overexpress a protein called HER2. Trastuzumab is most commonly used in HER2-positive breast cancer and HER2-positive gastric or gastro-oesophageal cancer. Trastuzumab is prescribed only after testing confirms that the cancer is HER2-positive, because trastuzumab works specifically against this target. If you have been prescribed trastuzumab, it means your cancer has a feature that makes trastuzumab an appropriate treatment option.

Trastuzumab works by attaching to the HER2 protein on the surface of cancer cells. HER2 sends signals that encourage cancer cells to grow and divide. By binding to HER2, trastuzumab blocks these growth signals and also helps the immune system recognise and attack the cancer cells. Trastuzumab slows cancer growth and can reduce the risk of cancer progression or recurrence when used as part of a treatment plan. Trastuzumab does not act like traditional chemotherapy and does not affect all rapidly dividing cells in the same way.

Trastuzumab is given by intravenous infusion or, in some cases, by subcutaneous injection. Trastuzumab is administered in a hospital or clinic by trained healthcare professionals. The first dose of trastuzumab is usually given more slowly so that staff can monitor for any reactions. Subsequent doses of trastuzumab are often given more quickly if the first dose is well tolerated. Trastuzumab is usually given every one, two or three weeks, depending on your treatment schedule.

Before starting trastuzumab, your doctor will check your heart function, usually with an echocardiogram or similar test. This is because trastuzumab can affect heart function in some people. Heart monitoring continues at regular intervals during trastuzumab treatment. This monitoring is routine and is done to identify any early changes so treatment can be adjusted if needed.

Now let?s talk about what to expect while receiving trastuzumab.
Infusion-related reactions are most likely to occur with the first trastuzumab dose. These reactions may include fever, chills, headache, nausea, flushing, rash or shortness of breath. These symptoms usually occur during or shortly after the infusion. Nurses monitor you closely during trastuzumab administration and can slow or stop the infusion and give supportive medicines if needed. Most people tolerate later doses of trastuzumab much better.

Fatigue is a common side effect of trastuzumab. This may be mild to moderate and can build up over time. Fatigue may also be influenced by other cancer treatments given alongside trastuzumab. Balancing rest and activity can help manage this.

Trastuzumab can cause mild gastrointestinal symptoms such as nausea or diarrhoea, although these are generally less severe than with traditional chemotherapy. Report persistent or worsening symptoms so they can be managed early.

The most clinically important potential side effect of trastuzumab involves the heart. Trastuzumab can reduce the heart?s pumping ability in some patients. This is usually reversible when trastuzumab is paused or stopped, but early detection is important. You should report symptoms such as shortness of breath, swelling of the ankles or feet, unexplained weight gain, persistent cough, or unusual fatigue. Regular heart monitoring during trastuzumab treatment is a key safety measure.

Trastuzumab does not usually cause hair loss on its own. If hair loss occurs, it is often due to other chemotherapy medicines used in combination with trastuzumab.

Trastuzumab can slightly increase the risk of infections. Report fever, chills, sore throat or other signs of infection promptly.

Trastuzumab is not safe to use during pregnancy, as it can harm an unborn baby. Effective contraception is required during trastuzumab treatment and for the period recommended after the last dose. If pregnancy is suspected while receiving trastuzumab, contact your doctor immediately.

Trastuzumab is often given for a defined duration, such as one year in early breast cancer, or continued longer in advanced cancer depending on response and tolerance. Even if you feel well, it is important to attend all trastuzumab appointments so treatment remains consistent.

If you miss a trastuzumab appointment, contact your treatment centre as soon as possible so it can be rescheduled. Do not assume a missed dose is unimportant.

Trastuzumab can be used alongside other cancer medicines. Side effects you experience may be due to trastuzumab, other treatments, or the combination. Always report new or worsening symptoms rather than trying to identify the cause yourself.

As your pharmacist, my role is to help you understand what trastuzumab is, why trastuzumab has been prescribed, what side effects to watch for, and when to seek medical advice. I do not adjust trastuzumab doses or manage heart monitoring, but I can help reinforce safety information and answer medicine-related questions.

Trastuzumab is a well-established targeted therapy for HER2-positive cancers. Understanding how trastuzumab works and what to expect helps you stay informed, recognise important symptoms early, and take an active role in your trastuzumab treatment.